If you take this common medicine, talk to your doctor now, FDA warns
A large pharmaceutical company recalls some pills due to health risk.
HavingHypertension is a disturbing current condition in the United States according to disease control and prevention centers (CDC), 47% of US adults have beendiagnosed with hypertension Or take medication to deal with it. But if you are one of the millions of people using medications to treat high blood pressure, you need to know a safety reminder that a large pharmaceutical company has just published. Read it to see which drugs are drawn and if you have to make an appointment with your doctor immediately.
RELATED:If you use this popular moisturizer, stop immediately, FDA warns.
Pfizer recalls six large quinapril tablets and generic chlorhyrhelhazide.
March 21, Pfizer announced a voluntary recall on six manyLack tablets, a lot of quinapril and hydrochlorothiazide tablets, and four of many HCl / Hydrochlorothiazide Quinapril tablets used for the treatment of hypertension. The affected products were distributed to the 50 states and Puerto Rico from November 2019 to March 2022.
The pills are recalled because they contain high levels of a cancer-causing substance.
Pfizer said he had issued the reminder after discovering that some of the many drugs hadLevels of nitrosamineN-Nitroso-Quinapril, which exceeded the acceptable daily admission limit of the food and medicine administration (ADA) on Nitrosamine of 26.5 ng / day.AE0FCC31AE342FD3A1346EBB1F342FCB
"Nitrosamines are common in water and food, including hardened and grilled meats, dairy products and vegetables," wrote Pfizer when noticeable. "Everyone is exposed to a certain level of nitrosamines. These impurities can increase the risk of cancer if people are exposed to them above acceptable levels over long periods."
RELATED:For more information up to date, sign up for our daily newsletter.
This is not the first reminder of nitrosamine drugs.
The FDA has begun to define acceptable limits across the industry forImpurities of nitrosamine in medicines In 2020, according to the section of the website of the Agency devoted to this continuous problem. "Impurities of nitrosamine can increase the risk of cancer if the people exposed above acceptable levels and long periods, but a person taking a medicine containing nitrosamines below acceptable daily admission limits Every day for 70 years. Should not have an increased risk of cancer, "explains the FDA.
The same day as the announcement of the pfizer reminder,pharmaceutical company Sandoz Inc. announced that it issued a national recall of 13 a lot of 100 mg prolonged release orpherenadrin tablets (ER) after a "nitrosamine impurity" were found during recent tests. The other drugs that have been drawn from the market for the same reason in the past include drugs against burns of burns (strongly sold on-le-counter like Zantac) and theMedicine of diabetes meformine.
Here's what you should do if you have any drugs recalled in your medicine cabinet.
Pfizer says it has not yet received reports of adverse effects at theRecalled medications. However, the company suggests that anyone who took these tablets should immediately contact their doctor or health care provider to determine if their order was affected by the reminder.
"Although N-Nitroso-Quinapril's long-term ingestion can be associated with a potential risk of increased cancer in humans, there is no immediate risk for patients taking this medicine," wrote Pfizer in his opinion. "Patients currently taking products should consult their doctor about alternative treatment options."
Anyone with product questions can also call the Sedgwick Claim Management Service at 888-843-0247 from 8h to 5 hours. And weekdays for more information on how tablets can be returned for a refund.
RELATED:If you have any of these 7 drugs, stop using them now, FDA warns.
